Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EPS (Basic): 2009-2025

Historic EPS (Basic) for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$0.05.

  • Rockwell Medical's EPS (Basic) fell 200.00% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 260.00%. This contributed to the annual value of -$0.03 for FY2024, which is 91.89% up from last year.
  • Rockwell Medical's EPS (Basic) amounted to -$0.05 in Q3 2025, which was down 0.00% from -$0.05 recorded in Q2 2025.
  • Rockwell Medical's 5-year EPS (Basic) high stood at $0.05 for Q3 2024, and its period low was -$1.04 during Q4 2021.
  • For the 3-year period, Rockwell Medical's EPS (Basic) averaged around -$0.05, with its median value being -$0.05 (2025).
  • Its EPS (Basic) has fluctuated over the past 5 years, first tumbled by 1,055.56% in 2021, then skyrocketed by 171.43% in 2024.
  • Rockwell Medical's EPS (Basic) (MRQ) stood at -$1.04 in 2021, then skyrocketed by 95.19% to -$0.05 in 2022, then rose by 0.00% to -$0.05 in 2023, then grew by 20.00% to -$0.04 in 2024, then decreased by 25.00% to -$0.05 in 2025.
  • Its last three reported values are -$0.05 in Q3 2025, -$0.05 for Q2 2025, and -$0.04 during Q1 2025.